Portugal Pharmaceuticals and Healthcare Report Q2 2010

Executive Summary.................................................... 5
SWOT Analysis ........................................................... 6
Portugal Pharmaceuticals And Healthcare Industry SWOT..............................................6
Portugal Political SWOT..............7
Portugal Economic SWOT ................................................................................................7
Pharmaceutical Business Environment Ratings.......................................................................................... 8
Table: Western Europe Pharmaceutical Business Environment Ratings For Q210 ...........8
Limits To Potential Returns...............................................................................................9
Risks To Realisation Of Returns........................................................................................9
Portugal – Market Summary ..................................... 11
Regulatory Regime ................................................... 13
Table: Number Of Marketing Authorisations Issued In Portugal....................................14
Table: Number Of Medicines With Marketing Authorisation ...........................................14
Parallel Imports ..........................15
Recent EU Regulatory Developments..............................................................................15
Pricing Regime............................16
Generic Drugs.............................19
Reimbursement Regime ...............19
Pharmacoeconomics ...................20
Industry Trends And Developments........................ 21
Epidemiology ..............................21
Table: Number Of Deaths In Portugal According To Disease .........................................23
Healthcare System.......................23
Pharmaceutical Industry .................................................................................................24
Recent Company Developments ......................................................................................24
Wholesale Sector.........................25
Pharmacy Sector .........................26
Clinical Research........................26
Medical Devices..........................27
Industry Forecast Scenario ...................................... 28
Key Growth Factors – Industry.......................................................................................30
Macroeconomic Outlook .................................................................................................32
Table: Portugal –- Economic Activity .............................................................................34
Table: Portugal Long-Term Macroeconomic Forecasts .................................................34
Prescription Drug Market Forecast ................................................................................35
Patented Drug Market Forecast......................................................................................37
Generic Drug Market Forecast .......................................................................................38
Table: Top 10 Generic Drugs By Value In 2008 .............................................................39
OTC Medicine Market Forecast......................................................................................40
Table: Top Ten Non-Prescription Drugs Sold Outside Pharmacies By Volume, January-October 2008 .............................................................41
Pharmaceutical Trade Forecast......................................................................................42
Other Healthcare Data Forecasts ...................................................................................43
Key Risks To Forecasts ........................................................................................43
Competitive Landscape ........................................... 44
Table: Number Of Pharmaceutical Companies, Wholesalers, Pharmacies, Pharmacy Extensions And Drug Stores In Portugal .......................44
Company Profiles ..................................................... 45
Hovione.......................................45
Bial..............................................47
Medinfar......................................49
Ratings Overview ........................52
Table: Pharmaceutical Business Environment Indicators...............................................53
Weighting ....................................54
Table: Weighting Of Components ...................................................................................54
Sources........................................54
Forecast Tables......................................................... 55